An interventional study of Exercise session and Control session in Post-Acute COVID-19 Syndrome, sponsored by University of Nove de Julho. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-04.
Sponsored by University of Nove de Julho · Not applicable, Interventional, and Treatment
The objective of the study is to compare the acute cardiorespiratory and perceptual responses to a physical exercise session in those infected by Covid-19 with and without persistent symptoms.
The study will be a crossover carried out in two groups (with and without persistent symptoms of Covid-19). Participants in both groups will undergo a control session and an exercise session and cardiorespiratory and perceptual responses will be obtained before, during and after the sessions. In the exercise session, participants will perform aerobic exercises, strength exercises and muscle stretching, while in the control session participants will remain seated. Blood pressure, heart rate, cardiac autonomic modulation, peripheral oxygen saturation, vascular function and perception of affect will be obtained.
536 studies on the registry are indexed under Post-Acute COVID-19 Syndrome; 187 are open to participants now.
This study's planned enrollment of 40 is below the median of 60 across 369 interventional studies indexed under Post-Acute COVID-19 Syndrome.
Browse Post-Acute COVID-19 Syndrome studies →University of Nove de Julho is the lead sponsor of 246 studies on the registry; 52 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 1 (13%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Post-Covid Syndrome group:
Healthy group:
In the exercise session, participants will perform aerobic, free active and flexibility exercises and will last approximately 45 minutes.
Behavioral: Exercise session · Behavioral: Control session
In the control session, participants will remain seated for 60 minutes.
Behavioral: Exercise session · Behavioral: Control session
Session will included aerobic, resistance and flexibility exercises and will last approximately 45 minutes. The session will begin with aerobic exercises (5 min jumping jacks and 5 min stationary walking). Then, nine strength exercises will be performed for the main muscle groups (3 times of 12 to 15 repetitions, with a 1-minute rest interval) and finally stretching for the main muscle groups
Also known as: Rehabilitation, Cardiorespiratory exercises, Resistance exercises, Flexibility
Remain seated for 60 min
Change in Blood pressure
Assessment of the systolic and diastolic blood pressure using an automatic device
Time frame: Before and 30 and 50 minutes after the end of the exercise and control interventions
Change in Heart rate variability
Assessment of the heart rate variability indicators using a heart rate monitor
Time frame: Before and 30 and 50 minutes after the end of the exercise and control interventions
Change in flow mediated dilation
Assessment of the flow mediated dilation using a doppler ultrasound
Time frame: Before and 30 minutes after the end of the exercise and control interventions
Change in peak exhalation flow
Assessment of the peak exhalation flow using a peak flow device
Time frame: Before and 5 minutes after the end of the exercise and control interventions
Change in oxygen saturation
Assessment of the peripheral oxygen saturation using a pulse oximeter
Time frame: Before, during and 5 minutes after the end of the exercise and control interventions
Change in heart rate
Assessment of heart rate using a heart rate monitor
Time frame: Before and continuously during exercise and control interventions
Change in affective response
Assessment of affective response using a felling scale
Time frame: Before and every 5 minutes during exercise and control interventions
Plan to share: Undecided — Plan to share the data after completion upon resonable request
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Post-Acute COVID-19 Syndrome →